ArticleInsights into imaging2025
CT-based radiomics deep learning signatures for non-invasive prediction of metastatic potential in pheochromocytoma and paraganglioma: a multicohort study.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Research on machine learning-based clinical prediction models: a bibliometric analysis.Frontiers in oncology · 2026Pooled it
- Biomarkers of metastatic disease in pheochromocytoma and paraganglioma.Endocrine connections · 2026Article
- The application of artificial intelligence in adrenal imaging: current state of knowledge, challenges, and future directions.Endocrine connections · 2026Article
- Multi-omics insights into metastatic pheochromocytomas and paragangliomas: Mechanisms, signatures, and prediction models.Hormones (Athens, Greece) · 2026Review
- CT-Based Nested Habitats Analysis for Early Recurrence Prediction and Risk Stratification in Hepatocellular Carcinoma: Development and Multicenter Validation Across Four Cohorts.Annals of surgical oncology · 2026Article
- Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided management.Insights into imaging · 2026Article
- Artificial Intelligence and Machine Learning in Pediatric Endocrine Tumors: Opportunities, Pitfalls, and a Roadmap for Trustworthy Clinical Translation.Biomedicines · 2026Review
- Machine learning based on body composition radiomics for predicting early recurrence in colorectal cancer: a multicenter study.Frontiers in nutrition · 2026Article
- An interpretable machine learning framework using multi-phase computed tomography for differentiation of adrenal lipid-poor adenomas and pheochromocytomas.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to develop and validate CT-based radiomics deep learning signatures for the non-invasive prediction of metastatic potential in pheochromocytomas and paragangliomas (PPGLs).
methodsWe conducted a retrospective analysis of 249 PPGL patients from three institutions, dividing them into training (n = 138), test1 (n = 71), and test2 (n = 40) sets. Based on the grading system for adrenal pheochromocytoma and paraganglioma (GAPP), patients were classified into low-risk (GAPP < 3) and high-risk (GAPP ≥ 3) groups. Radiomic features were extracted from CT venous phase images and modeled using six machine learning algorithms. The maximum 2D sections and 3D images of each tumor were input into four ResNet models to obtain predictive probabilities. Optimal models were selected based on receiver operating characteristic analysis and integrated with radiological features to develop a combined model, which was evaluated on external datasets, and explored prognostic information.
resultsThe support vector machine radiomics and 2D ResNet-50 models demonstrated good performance. By integrating these two models with intratumoral necrosis features, we constructed a combined model that achieved high accuracy, with area under the curve (AUC) values of 0.90 for the training, 0.86 for the test1, and 0.88 for the test2 sets. This model effectively stratified patients based on metastasis-free survival (p = 0.003). Its predictive ability remains robust below the 6 cm threshold, with AUC values exceeding 0.87 across all datasets.
conclusionsThe combined model can predict the metastatic potential of PPGL in the preoperative stage, providing a precise surgical strategy for pheochromocytoma regarding the 6 cm surgical threshold. CRITICAL RELEVANCE STATEMENT: The combined model, established based on radiomic and deep learning signatures, shows potential for early preoperative prediction of metastatic potential in PPGL. KEY POINTS: Metastatic potential of PPGL affects surgical approaches and prognosis. CT-based radiomics deep learning signatures can predict the metastatic potential in PPGL.3. The combined model's predictive ability remains robust below the 6-cm threshold. The combined model's predictive ability remains robust below the 6-cm threshold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.